Trending Now: Hematopoietic Stem Cells Transplantation Market 2020: Global Size, Supply-Demand, Product Type and End User Analysis To 2026| CBR…

LOS ANGELES, United States: QY Research has recently published a report, titled Global Hematopoietic Stem Cells Transplantation Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. The research report gives the potential headway openings that prevails in the global market

Read more
Vitalant to Hold Two Blood Donation Drives in Monmouth County to Assist Health Care Facilities Hardest Hit by Coronavirus – TAPinto.net

Companies, Organizations Needed to Host Events MONTVALE, NJ Because of the current, nationwide surge in COVID-19 infections throughout the Sun Belt, along with the constant importance of bolstering the local blood supply, theres now significant need for residents to donate blood and, if possible, convalescent plasma. The nonprofit, blood-collection organization Vitalantis offering two local, open-to-the-public donation events during August: Sign Up for Belmar/Lake Como Newsletter Our newsletter delivers the local news that you can trust

Read more
Hematopoietic Stem Cells Transplantation Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026|CBR Systems, China Cord…

QY Research has Published Latest Trending Report on Global Hematopoietic Stem Cells Transplantation Market Los Angeles, United State, The report titledGlobal Hematopoietic Stem Cells Transplantation Marketis one of the most comprehensive and important additions to QY Researchs archive of market research studies.

Read more
Shady Stem Cell Therapies Can Cause Tumors, Infections, and Death, Doctors Report – Gizmodo

A researcher holding up a container of stem cells.Photo: Spencer Platt (Getty Images) A team of neurologists are raising a red flag over risky and unproven stem cell therapies. Their new study suggests that their fellow doctors are frequently asked about these controversial procedures by desperate patients. Many doctors are also seeing patients with serious complications from stem cell therapy, including seizures, infections, and spinal tumors

Read more
Biobanking Market worth $2.69 billion according to a new research report – WhaTech Technology and Markets News

North America is expected to account for the largest share of the Biobanking Devices Market According to the new market research report "Biobanking Market by Product and Service(Equipment, Consumables, Services, Software), Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids), Application( Regenerative Medicine, Life Science, Clinical Research) - Global Forecast" published by MarketsandMarkets The Biobanking Market is expected to reach $2.69 billion, at a CAGR of 7.8%.

Read more
Can progenitor cells go further than gene therapy in retinal disorders? A biotech’s answer shines in PhIIb – Endpoints News

By the time the FDA approved Luxturna the pioneering gene therapy for an inherited retinal disease Henry Klassen had been researching and treating the group of diseases known as retinitis pigmentosa for more than 20 years. Spark Therapeutics success there had not just inspired a $4.3 billion takeover by Roche, it had also emboldened other biotechs pursuing a therapy that would deliver one of the genes tied to different variations of the disorder. Nightstar Therapeutics subsequently scored its own buyout with Biogen, and MeiraGTx recently posted early but exciting data on its J&J-partnered program.

Read more